Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today filed a resale shelf Registration Statement on Form S-1 with the Securities and Exchange Commission (“SEC”) relating to the potential future sales by a subsidiary of Elan Corporation, plc (“Elan”) of up to 31,900,000 ordinary shares of Alkermes plc (“Alkermes”), pursuant to the shareholder’s agreement between Alkermes and Elan entered into in connection with the business combination of Elan’s drug technology unit and Alkermes, Inc., whic

Feed Date: 
February 16, 2012